Skip to content

CS Professional · CSR and Social Governance · Impact of CSR

Ganga Pharma Ltd commissions its own implementing partner to evaluate a health project it funds. The partner's renewal depends on the company, and the report shows only favourable results, omitting beneficiaries who dropped out. Which pair of limitations best describes the weakness in this assessment?

The weaknesses are lack of evaluator independence and selection or survivorship bias. The partner depends on the company for renewal, so it has an incentive to report favourably, and ignoring dropouts inflates results by counting only those who stayed. Credible impact assessment needs an independent evaluator and full coverage of beneficiaries.

  1. AEvaluator independence and selection or survivorship biasCorrect
  2. BExcess of third-party verification and over-reporting of costs
  3. CUse of a control group and a long baseline
  4. DLack of any intended outcomes and an excess of statutory approvals

Explanation

The evaluator has a financial interest in a good report, so independence is compromised. Leaving out dropouts means only those who remained are counted, which is survivorship or selection bias that inflates results. The other options describe features that are absent or irrelevant here.

Did you get it right without looking?

One question tells you little. A timed set on Impact of CSR shows your real accuracy, how long you take and where you lose marks.

Practise Impact of CSRFree diagnostic mock

More Impact of CSR questions